- NCIt
- C4242
Loading cancer entity…
Loading cancer entity…
Clinical trials
461 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01069120 | Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids | terminated | Phase 3 | 27 | Repros Therapeutics Inc.INDUSTRY | 1 | Aug 21, 2014 | clinicaltrials |
| NCT01311869 | Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids | terminated | Phase 2 | 43 | Meharry Medical CollegeOTHER | 1 | Oct 24, 2013 | clinicaltrials |
| NCT00496080 |
| Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding(DUAO) |
| terminated |
| N/A |
| 87 |
| Ethicon, Inc.INDUSTRY |
| 3 |
| Sep 10, 2012 |
| clinicaltrials |
| NCT00496067 | Uterine Artery Occlusion for Fibroid Related Bleeding | terminated | N/A | 91 | Ethicon, Inc.INDUSTRY | 7 | Mar 9, 2011 | clinicaltrials |
| NCT01140555 | A Pilot Study to Determine Optimal Procedure Steps to Obtain and Maintain Uterine Artery Occlusion With the D-UAO Device | terminated | N/A | 2 | Ethicon, Inc.INDUSTRY | 4 | Feb 17, 2011 | clinicaltrials |
| NCT00584207 | Radiofrequency Ablation of Uterine Fibroids | terminated | Early Phase 1 | 15 | University of California, DavisOTHER | 1 | Apr 23, 2009 | clinicaltrials |
Data updated 22 days agoSource updated Aug 21, 2014source: clinicaltrials